STRIPE partners in precision medicine series: provider perspective

Christine M Formea¹, Paldeep Atwal^{2

3}, Kathryn Meintsma⁴, Martin Dawes⁵, Gary Marchant⁶, Ben L Kong⁷, J Shawn Jones⁸, Sara L Rogers^{9

10

11

12}

Affiliations

¹ Department of Pharmacy and Precision Medicine Institute, Children's Hospital Colorado, Aurora, CO, USA. Christine.Formea@childrenscolorado.org.
² Atwal Clinic, Palm Beach, FL, USA.
³ Everly Health Solutions, Austin, TX, USA.
⁴ HealthRoad Legal, PLLC, Watertown, MN, USA.
⁵ Department of Family Practice, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
⁶ Center for Law, Science & Innovation, Sandra Day O'Connor College of Law, Arizona State University, Phoenix, AZ, USA.
⁷ Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.
⁸ Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, Dallas, TX, USA.
⁹ Department of Pharmacy Practice, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX, USA.
¹⁰ Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Bryan, TX, USA.
¹¹ Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA.
¹² American Society of Pharmacovigilance, Houston, TX, USA.

Review

Christine M Formea et al. Pharmacogenomics J. 2024.

. 2024 Aug 23;24(5):28.

doi: 10.1038/s41397-024-00348-9.

Christine M Formea¹, Paldeep Atwal^{2

3}, Kathryn Meintsma⁴, Martin Dawes⁵, Gary Marchant⁶, Ben L Kong⁷, J Shawn Jones⁸, Sara L Rogers^{9

10

11

12}

¹ Department of Pharmacy and Precision Medicine Institute, Children's Hospital Colorado, Aurora, CO, USA. Christine.Formea@childrenscolorado.org.
² Atwal Clinic, Palm Beach, FL, USA.
³ Everly Health Solutions, Austin, TX, USA.
⁴ HealthRoad Legal, PLLC, Watertown, MN, USA.
⁵ Department of Family Practice, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
⁶ Center for Law, Science & Innovation, Sandra Day O'Connor College of Law, Arizona State University, Phoenix, AZ, USA.
⁷ Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.
⁸ Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, Dallas, TX, USA.
⁹ Department of Pharmacy Practice, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX, USA.
¹⁰ Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Bryan, TX, USA.
¹¹ Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA.
¹² American Society of Pharmacovigilance, Houston, TX, USA.

No abstract available

References

1. Dawes M, Aloise MN, Ang JS, Cullis P, Dawes D, Fraser R, et al. Introducing pharmacogenetic testing with clinical decision support into primary care: A feasibility study. CMAJ Open. 2016;4:E528–E534. - DOI - PMC
1. Smith H, Dawes M, Katzov-Eckert H, Burrell S, Xin Hui S, Winther MD Improving prescribing: A feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore. Fam Pract. 2022; cmac124. https://doi.org/10.1093/fampra/cmac124 .
1. Marchant GE, Lindor R. Genetic malpractice: An emerging tide or gentle ripple? Food and Drug Law J. 2018;73:1–37.
1. Novartis Pharmaceuticals Corporation. Tegretol (carbamazepine) prescribing information. www.accessdata.fda.gov/drugsatfda_docs/label/2015/016608s097,018281s045,... (accessed 2023 Sept 20).